Humanigen Announces $71,800,000 Equity Financing
Post# of 148177
I posted about their drug, lenzilumab, on 4/15, and their stock has TRIPLED in the last 4 days and is crushing it today as well. Looks so much like leronlimab in connection with the cytokine storm, but these guys are in bed with Kite/Gillead already. Makes me wonder why CYDY wasn't/isn't. Anyone have any thoughts? Link to article below. And just in case anyone is wondering, I am still long and strong CYDY, just keeping an eye on what may be the competition.
https://apnews.com/572d06285f68b0a658e4af4f8403bea9